Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria-Reference-Cited by-同舟云学术

Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria

Published:2005-05 Issue:24 Volume:23 Page:3131-3138
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Malkin Elissa M.,Durbin Anna P.,Diemert David J.,Sattabongkot Jetsumon,Wu Yimin,Miura Kazutoyo,Long Carole A.,Lambert Lynn,Miles Aaron P.,Wang Jin,Stowers Anthony,Miller Louis H.,Saul Allan

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference15 articles.

1. The neglected burden of Plasmodium vivax malaria;Mendis;Am J Trop Med Hyg,2001

2. Progress and challenges for malaria vaccines;Richie;Nature,2002

3. Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates;Tsuboi;Mol Med,1998

4. Current developments in malaria transmission-blocking vaccines;Stowers;Expert Opin Biol Ther,2001

5. Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes;Hisaeda;Infect Immun,2000

Cited by 204 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity and transmission-blocking potential of quiescin sulfhydryl oxidase in Plasmodium vivax;Frontiers in Cellular and Infection Microbiology;2024-08-27

2. Antibody gene features associated with binding and functional activity in malaria vaccine-derived human mAbs;npj Vaccines;2024-08-10

3. Evaluation of combination vaccines targeting transmission of Plasmodium falciparum and P. vivax;Vaccine;2024-08

4. Malaria vaccines: a new era of prevention and control;Nature Reviews Microbiology;2024-07-18

5. Immunogenicity of PvCyRPA, PvCelTOS and Pvs25 chimeric recombinant protein of Plasmodium vivax in murine model;Frontiers in Immunology;2024-06-19